Additionally, the downstream effector c-Jun and its phosphorylated form were consistently reduced in HCC TPC2 KO cells (Supplementary Figures S7I, K), further supporting suppression of MAPK/JNK signalling upon TPC2 ablation. Here, JUN is linked to hepatocellular carcinoma.